华海药业：产品取得注册证

每日经济新闻09-18

每经AI快讯，华海药业（SH 600521，收盘价：16.18元）9月18日晚间发布公告称，浙江华海药业股份有限公司及下属控股子公司长兴制药股份有限公司于近日收到国家药品监督管理局核准签发的《药品注册证书》。包括“马来酸依那普利片剂型”等产品。2023年1至12月份，华海药业的营业收入构成为：成品药销售占比59.35%，原材料及中间体销售占比38.03%，技术服务占比1.47%，其他行业占比...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2468730383?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-09-18 17:23","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2468730383","market":"sh","top_or_hot":-1,"title":"华海药业：产品取得注册证","media":"每日经济新闻","content":"<div>\n<p>每经AI快讯，华海药业（SH 600521，收盘价：16.18元）9月18日晚间发布公告称，浙江华海药业股份有限公司及下属控股子公司长兴制药股份有限公司于近日收到国家药品监督管理局核准签发的《药品注册证书》。包括“马来酸依那普利片剂型”等产品。2023年1至12月份，华海药业的营业收入构成为：成品药销售占比59.35%，原材料及中间体销售占比38.03%，技术服务占比1.47%，其他行业占比...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409181723429f04c709&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>华海药业：产品取得注册证</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n华海药业：产品取得注册证\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-18 17:23 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409181723429f04c709&s=b><strong>每日经济新闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>每经AI快讯，华海药业（SH 600521，收盘价：16.18元）9月18日晚间发布公告称，浙江华海药业股份有限公司及下属控股子公司长兴制药股份有限公司于近日收到国家药品监督管理局核准签发的《药品注册证书》。包括“马来酸依那普利片剂型”等产品。2023年1至12月份，华海药业的营业收入构成为：成品药销售占比59.35%，原材料及中间体销售占比38.03%，技术服务占比1.47%，其他行业占比...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409181723429f04c709&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"600521","symbol_name":"华海药业","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409181723429f04c709&s=b","article_id":"2468730383","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409181723429f04c709&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2468730383","pubTimestamp":1726651402,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"每经AI快讯，华海药业 9月18日晚间发布公告称，浙江华海药业股份有限公司及下属控股子公司长兴制药股份有限公司于近日收到国家药品监督管理局核准签发的《药品注册证书》。2023年1至12月份，华海药业的营业收入构成为：成品药销售占比59.35%，原材料及中间体销售占比38.03%，技术服务占比1.47%，其他行业占比0.36%，进出口贸易占比0.06%。截至发稿，华海药业市值为237亿元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600521":"华海药业","BK0239":"医药制造","BK0188":"融资融券","BK0028":"国家队","BK0070":"员工持股","BK0201":"可转债","BK0012":"证金概念","BK0185":"二线龙头"},"translate_title":"Huahai Pharmaceutical: Product obtained registration certificate","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600521":1},"content_text":"每经AI快讯，华海药业（SH 600521，收盘价：16.18元）9月18日晚间发布公告称，浙江华海药业股份有限公司及下属控股子公司长兴制药股份有限公司于近日收到国家药品监督管理局核准签发的《药品注册证书》。包括“马来酸依那普利片剂型”等产品。2023年1至12月份，华海药业的营业收入构成为：成品药销售占比59.35%，原材料及中间体销售占比38.03%，技术服务占比1.47%，其他行业占比0.36%，进出口贸易占比0.06%。截至发稿，华海药业市值为237亿元。道达号（daoda1997）“个股趋势”提醒：1. 华海药业近30日内北向资金持股量增加120.00万股，占流通股比例增加0.09%；2. 近30日内无机构对华海药业进行调研。每经头条（nbdtoutiao）——百亿国货呼之欲出，国内美妆争流量还卷成分(记者 蔡鼎)","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.0","shortVersion":"4.29.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2468730383"}